CoChat

Fine-tuning of BERT Model to Accurately Predict Drug–Target Interactions

Open access
Kang, Hyeunseok, Goo, Sungwoo, Lee, Hyunjung, Chae, Jung-woo, Yun, Hwi-yeol, Jung, Sangkeun · 2022 · Pharmaceutics
Cited by 68

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Abstract

The identification of optimal drug candidates is very important in drug discovery. Researchers in biology and computational sciences have sought to use machine learning (ML) to efficiently predict drug–target interactions (DTIs). In recent years, according to the emerging usefulness of pretrained models in natural language process (NLPs), pretrained models are being developed for chemical compounds and target proteins. This study sought to improve DTI predictive models using a Bidirectional Encoder Representations from the Transformers (BERT)-pretrained model, ChemBERTa, for chemical compounds. Pretraining features the use of a simplified molecular-input line-entry system (SMILES). We also employ the pretrained ProBERT for target proteins (pretraining employed the amino acid sequences). The BIOSNAP, DAVIS, and BindingDB databases (DBs) were used (alone or together) for learning. The final model, taught by both ChemBERTa and ProtBert and the integrated DBs, afforded the best DTI predictive performance to date based on the receiver operating characteristic area under the curve (AUC) and precision-recall-AUC values compared with previous models. The performance of the final model was verified using a specific case study on 13 pairs of subtrates and the metabolic enzyme cytochrome P450 (CYP). The final model afforded excellent DTI prediction. As the real-world interactions between drugs and target proteins are expected to exhibit specific patterns, pretraining with ChemBERTa and ProtBert could teach such patterns. Learning the patterns of such interactions would enhance DTI accuracy if learning employs large, well-balanced datasets that cover all relationships between drugs and target proteins.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/pharmaceutics14081710

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 14

  1. Unterthiner, T., Mayr, A., Klambauer, G., Steijaert, M., Wegner, J.K., Ceulemans, H., and Hochreiter, S. (2014, January 8–13). Deep learning as an opportunity in virtual screening. Proceedings of the Deep Learning Workshop at NIPS, Montreal, QC, Canada.
  2. Wen, 2017, Deep-learning-based drug–target interaction prediction, J. Proteome Res., 16, 1401, 10.1021/acs.jproteome.6b00618 · DOI · Paper page
  3. Ozkirimli, 2018, DeepDTA: Deep drug–target binding affinity prediction, Bioinformatics, 34, i821, 10.1093/bioinformatics/bty593 · DOI · Paper page
  4. Öztürk, H., Ozkirimli, E., and Özgür, A. (2019). WideDTA: Prediction of drug-target binding affinity. arXiv. · DOI · Paper page
  5. Vaswani, A., Shazeer, N., Parmar, N., Uszkoreit, J., Jones, L., Gomez, A.N., Kaiser, Ł., and Polosukhin, I. (2017, January 4–9). Attention is all you need. Proceedings of the Advances in Neural Information Processing Systems 30 (NIPS 2017), Long Beach, CA, USA.
  6. Chithrananda, S., Grand, G., and Ramsundar, B. (2020). Chemberta: Large-scale self-supervised pretraining for molecular property prediction. arXiv.
  7. Elnaggar, A., Heinzinger, M., Dallago, C., Rehawi, G., Wang, Y., Jones, L., Gibbs, T., Feher, T., Angerer, C., and Steinegger, M. (2021). ProtTrans: Towards Cracking the Language of Lifes Code Through Self-Supervised Deep Learning and High Performance Computing. IEEE Trans. Pattern Anal. Mach. Intell., 1. · DOI · Paper page
  8. Liu, 2007, BindingDB: A web-accessible database of experimentally determined protein–ligand binding affinities, Nucleic Acids Res., 35, D198, 10.1093/nar/gkl999 · DOI · Paper page
  9. Bepler, T., and Berger, B. (2019). Learning protein sequence embeddings using information from structure. arXiv.
  10. Liu, Y., Ott, M., Goyal, N., Du, J., Joshi, M., Chen, D., Levy, O., Lewis, M., Zettlemoyer, L., and Stoyanov, V. (2019). Roberta: A robustly optimized bert pretraining approach. arXiv.
  11. Girshick, R. (2015, January 7–13). Fast r-cnn. Proceedings of the IEEE International Conference on Computer Vision, Washington, DC, USA. · DOI · Paper page
  12. Huang, 2021, MolTrans: Molecular Interaction Transformer for drug–target interaction prediction, Bioinformatics, 37, 830, 10.1093/bioinformatics/btaa880 · DOI · Paper page
  13. Heller, 2005, Concordance probability and discriminatory power in proportional hazards regression, Biometrika, 92, 965, 10.1093/biomet/92.4.965 · DOI · Paper page
  14. Roy, 2013, Some case studies on application of “rm2” metrics for judging quality of quantitative structure–activity relationship predictions: Emphasis on scaling of response data, J. Comput. Chem., 34, 1071, 10.1002/jcc.23231 · DOI · Paper page

Cited by

See all 68

Metadata

Authors
Kang, H., Goo, S., Lee, H., Chae, J.-W., Yun, H.-Y., & Jung, S.
Venue
Pharmaceutics
Publisher
MDPI AG
Published
2022-08-16
Volume
14
Issue
8
Pages
1710
ISSN
1999-4923 (ISSN-L)
OpenAlex
W4292265045
Cited by
68
References
13
FWCI
6.71
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.